Molecular cloning and pharmacological chracterization of guinea pig 5-HT(1B) and 5-HT(1D) receptors

Neuropharmacology

Volumn 36, Issue 4-5, 1997, Pages 513-524

  Zgombick, J M ^a   Bard, J A ^a   Kucharewicz, S A ^a   Urquhart, D A ^a   Weinshank, R L ^a   Branchek, T A ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

5 HT(1B) receptor; 5 HT(1D) receptor; Amino acid sequences; Guinea pig; Human; Radioligand binding affinities; Species comparisons

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2 METHYLSEROTONIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 CARBAMOYLTRYPTAMINE; 5 METHOXYTRYPTAMINE; ALPHA METHYLSEROTONIN; CYANOIODOPINDOLOL; DIHYDROERGOTAMINE; KETANSERIN; METERGOLINE; METHYSERGIDE; METITEPINE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; OLIGONUCLEOTIDE; OXYMETAZOLINE; PINDOLOL; RADIOLIGAND; RAUWOLSCINE; RECEPTOR SUBTYPE; RITANSERIN; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; SPIPERONE; SUMATRIPTAN; TRYPTAMINE; YOHIMBINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA LIBRARY; DRUG SELECTIVITY; GENE EXPRESSION; GUINEA PIG; HUMAN; MIGRAINE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; SEQUENCE ANALYSIS; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; ANIMALS; CLONING, MOLECULAR; DOGS; GUINEA PIGS; HUMANS; LIGANDS; MICE; MOLECULAR SEQUENCE DATA; RABBITS; RATS; RECEPTORS, SEROTONIN; SEROTONIN AGENTS; SPECIES SPECIFICITY;

EID: 0030948625     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00023-3     Document Type: Article

References (50)

1. 1Dβ receptor. Molecular Pharmacology 41: 1-7.
2. 1F receptors for β-adrenergic antagonists. Neuropharmacology 33: 387-397.
3. 1F receptor. Society for Neuroscience Abstracts 22: 1330.
4. 1D-like receptor. Journal of Receptor Research 13: 479-502.
5. 1D subtypes. Naunyn-Schmiedeberg's Archives of Pharmacology 354: 237-244.
6. Bouchelet I., Cohen Z., Case B., Séguéla P. and Hamel E. (1996) Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Molecular Pharmacology 50: 219-223.
7. 1D binding sites. Journal of Pharmacology and Experimental Therapeutics 259: 1360-1365.
8. Bradford M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72: 248-254.
9. 1D receptors. In: Experimental Headache Models, eds J. Olesen and M. Moskowitz, pp. 123-134. Raven Press, New York.
10. 1D binding sites in various species: similar pharmacological profile in dog, monkey, calf, guinea-pig and human brain membranes. Naunyn-Schmiedeberg's Archives of Pharmacology 346: 243-248.
11. 1B binding sites in rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology 347: 569-582.
12. 1Dβ-like autoreceptors in the guinea-pig brain cortex. Naunyn-Schmiedeberg's Archives of Pharmacology 353: 281-289.
13. Buzzi M. G., Moskowitz M. A., Peroutka S. J. and Byun B. (1991) Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater. British Journal of Pharmacology 103: 1421-1428.
14. 1B receptor. Molecular Pharmacology 45: 20-28.
15. 50) of an enzymatic reaction. Biochemical Pharmacology 22: 3099-3108.
16. Cutrer F. M., Schoenfeld D., Limmroth V., Panahian N. and Moskowitz M. A. (1995) Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. British Journal of Pharmacology 114: 987-992.
17. Göthert M., Fink K., Frölich D., Likungu J., Molderings G., Schlicker E. and Zentner J. (1996) Presynaptic 5-HT autoand heteroreceptors in the human central and peripheral nervous system. Behavioural Brain Research 73: 89-92.
18. 1D serotonin receptors in the rat: structural and pharmacological comparison of the two cloned receptors. Molecular and Cellular Neuroscience 3: 578-587.
19. 1D binding sites. British Journal of Pharmacology 102: 227-233.
20. 1Dβ' receptors. European Journal of Pharmacology 242: 75-82.
21. 1D receptor genes. Trends in Pharmacological Sciences 13: 153-159.
22. 1D receptor subtypes. Trends in Pharmacological Sciences 17: 103-105.
23. 1Dβ receptors. FEBS Letters 377: 73-76.
24. 125I]iodocyanopindolol. European Journal of Pharmacology 118: 1-12.
25. Humphrey P. P. A. and Feniuk W. (1991) Mode of action of the anti-migraine drug sumatriptan. Trends in Pharmacological Sciences 12: 444-446.
26. 1Dβ receptors. Circulation 90: 1141-1153.
27. Lee W. S. and Moskowitz M. A. (1993) Conformationally-restricted sumatriptan analogues, CP-122,288 and CP-122,638, exhibit enhanced potency against neurogenic inflammation in dura mater. Brain Research 626: 303-305.
28. 1 receptor systemsin rat hippocampal membranes. Journal of Pharmacological Experimental Therapy 263: 1275-1284.
29. Manuel N. A., Wallis D. I. and Crick H. (1995) Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord. British Journal of Pharmacology 116: 2647-2654.
30. Maroteaux L., Saudou F., Amlaiky N., Boschert U., Plassat J. L. and Hen R. (1992) Mouse 5HT1B serotonin receptor: cloning, functional expression and localization in motor control centers. Proceedings of the National Academy of Sciences U.S.A. 89: 3020-3024.
31. 1D autoreceptors in human cerebral cortex. Journal of Neurochemistry 60: 1179-1181.
32. 355Asn site directed mutagenesis. Biochemical Pharmacology 44: 1917-1920.
33. Miller J. and Germain R. N. (1986) Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. Journal of Experimental Medicine 164: 1478-1489.
34. Moskowitz M. (1992) Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends in Pharmacological Sciences 13: 307-311.
35. 1B receptors. Nature 360: 161-163.
36. 1B receptors. Journal of Neurochemistry 60: 380-383.
37. 1D receptors regulate 5-HT release in rat raphe nuclei: in vivo voltammetry and in vitro superfusion studies. Neuropsychopharmacology 13: 249-260.
38. Razzaque Z., Longmore J. and Hill R. G. (1995) Differences in the effects of ketanserin and GR 127935 on 5-HT receptor-mediated responses in rabbit saphaneous vein and guinea-pig jugular vein. European Journal of Pharmacology 283: 199-206.
39. Roberts C., Watson J., Burton M., Price G. W. and Jones B. J. (1996) Functional characterization of the 5-HT terminal autoreceptor in guinea-pig brain cortex. British Journal of Pharmacology 117: 384-388.
40. Sanger F., Nicklen S. and Coulsen A. R. (1977) DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences U.S.A. 74: 5463-5467.
41. Southern E. M. (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 98: 503-517.
42. 1B receptor. EMBO Journal 10: 4017-4023.
43. 1F receptor binding sites in the guinea pig brain: an autoradiographic study. Naunyn-Schmiedeberg's Archives of Pharmacology 352: 263-275.
44. 2B-adrenergic receptor. Molecular Pharmacology 38: 681-688.
45. 1Dβ. Proceedings of the National Academy of Sciences U.S.A. 89: 3630-3634.
46. 1B receptors. Molecular Pharmacology 49: 761-765.
47. 1D receptor subtype. Molecular Pharmacology 40: 1036-1042.
48. 1Dβ receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s). Molecular Pharmacology 44: 575-582.
49. 1Dβ receptor subtypes. European Journal of Pharmacology (Molecular Pharmacology Section) 291:9-15.
50. 1D subtypes. Naunyn-Schmiedeberg's Archives of Pharmacology 352: 226-236.